Preventive Effects of a CVD Polypill on Developing Diabetes Among Patients With Metabolic Syndrome: Results of the PolyIran-Liver Trial DOI
Elham Jafari, Hossein Poustchi, Abbas Mohagheghi

и другие.

Archives of Iranian Medicine, Год журнала: 2024, Номер 27(10), С. 538 - 544

Опубликована: Окт. 1, 2024

Background: While cardiovascular disease (CVD) polypills have demonstrated significant benefits in preventing CVD events by managing risk factors and improving patient adherence, their effects on blood glucose levels, an important factor for CVD, remain unknown. Methods: We analyzed data from the PolyIran-Liver trial, which involved 1,508 participants aged 50 above. Of these, 787 were randomly assigned to receive a polypill (consisting of aspirin, atorvastatin, hydrochlorothiazide, valsartan), while 721 received usual care as control group over five-year period. The aim was determine whether there any differences fasting sugar (FBS) levels between two groups at baseline, middle, end study. analysis focused three subgroups: with diabetes, those metabolic syndrome (MetS) but without diabetes or MetS. Results: total studied population, mean age 59±6.7 years, 328(22%) identified 371 (25%) MetS 809 (54%) observed trend rising FBS until month 30, followed subsequent decline 60. Participants exhibited lower than both time points, statistically all subgroups 30 MetS-without 60 (mean difference: -9.3 mg/dl, 95% CI: 13.9 -4.6). Conclusion: used this study may potential delay onset patients more effectively general population. However, its beneficial diabetic individuals require further investigation.

Язык: Английский

Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024) DOI Open Access
Jian‐Gao Fan, Xiaoyuan Xu,

Rui-Xu Yang

и другие.

Journal of Clinical and Translational Hepatology, Год журнала: 2024, Номер 000(000), С. 000 - 000

Опубликована: Ноя. 4, 2024

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, dysfunction-associated non-alcoholic fatty liver disease has become most prevalent chronic disease. This condition frequently occurs Chinese patients with alcoholic hepatitis B. To address impending public health crisis its underlying issues, Society Hepatology Medical Association convened a panel clinical experts to revise update "Guideline prevention treatment (2018, China)". The new edition, titled for (Version 2024)", offers comprehensive recommendations on key including screening monitoring, diagnosis evaluation, treatment, follow-up steatotic Metabolic is now preferred English term used interchangeably Additionally, guideline emphasizes importance multidisciplinary collaboration among hepatologists other specialists manage cardiometabolic disorders effectively.

Язык: Английский

Процитировано

19

The Association Between Serum Gamma‐Glutamyl Transferase and Gastrointestinal Cancer Risk: A Systematic Review and Meta‐Analysis DOI Creative Commons
Alireza Ramandi, Jacob George, Amir Hossein Behnoush

и другие.

Cancer Medicine, Год журнала: 2025, Номер 14(2)

Опубликована: Янв. 1, 2025

ABSTRACT Background Gamma‐glutamyl transferase (GGT) has been shown to have associations with several diseases including cancers. Previous studies investigated the effect of GGT levels on gastrointestinal (GI) cancer incidence. We aim systematically investigate these provide better insights into interrelationship between and GI Methods Online databases were searched find relevant investigating different levels' effects incidence cancers colorectal, esophageal, liver, pancreas, gastric, biliary duct Random‐effect meta‐analysis was conducted pool hazard ratios (HRs) quartiles (Qs) Results A total 26 included in final review, 12 which underwent that 11 million patients. Based meta‐analysis, Q4 patients had a 69% higher (HR 1.69, 95% CI 1.41–2.02, p ‐value < 0.001). The ratio significance also similar for Q3 1.22, 1.15–1.30, 0.001) Q2 1.10, 1.05–1.16, =0.002) GGT. Colorectal liver showed among Q2, Q3, compared Q1. In pancreas bile cancers, only significantly HR. statistically significant gastric Conclusion Higher correlate rates incidence, especially colorectal hepatic Future should this biomarker's potential role risk assessment digestive

Язык: Английский

Процитировано

6

Liver diseases: epidemiology, causes, trends and predictions DOI Creative Commons

Can Gan,

Yuan Yuan, Haiyuan Shen

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2025, Номер 10(1)

Опубликована: Фев. 4, 2025

Abstract As a highly complex organ with digestive, endocrine, and immune-regulatory functions, the liver is pivotal in maintaining physiological homeostasis through its roles metabolism, detoxification, immune response. Various factors including viruses, alcohol, metabolites, toxins, other pathogenic agents can compromise function, leading to acute or chronic injury that may progress end-stage diseases. While sharing common features, diseases exhibit distinct pathophysiological, clinical, therapeutic profiles. Currently, contribute approximately 2 million deaths globally each year, imposing significant economic social burdens worldwide. However, there no cure for many kinds of diseases, partly due lack thorough understanding development these Therefore, this review provides comprehensive examination epidemiology characteristics covering spectrum from conditions manifestations. We also highlight multifaceted mechanisms underlying initiation progression spanning molecular cellular levels networks. Additionally, offers updates on innovative diagnostic techniques, current treatments, potential targets presently under clinical evaluation. Recent advances pathogenesis hold critical implications translational value novel strategies.

Язык: Английский

Процитировано

6

Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers DOI
Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan

и другие.

Metabolism, Год журнала: 2024, Номер 160, С. 156014 - 156014

Опубликована: Авг. 24, 2024

Язык: Английский

Процитировано

13

Reducing Premature Mortality from Cardiovascular Diseases in Low and Middle Income Countries: The Role of Polypill in Public Health Policy DOI Creative Commons
Sadaf G Sepanlou, SeyedehFatemeh Mousavi, Hossein Poustchi

и другие.

International Journal of Cardiology Cardiovascular Risk and Prevention, Год журнала: 2025, Номер 25, С. 200400 - 200400

Опубликована: Апрель 6, 2025

Premature deaths account for about half of all fatalities in developing countries. In low- and middle-income countries, cardiovascular diseases have consistently been the primary cause premature mortality men women during past three decades. Current evidence indicates that fixed-dose combination therapy, so-called Polypill, effectively reduces burden diseases, with greater benefits observed combinations include aspirin. Polypill demonstrates high adherence an acceptable safety profile, adverse drug events being comparable between groups receiving treatment those control group. Therefore, this paper advocates broader implementation low emphasizing its efficacy secondary prevention diseases. The strategy could also benefit high-risk special conditions, such as non-alcoholic fatty liver disease chronic kidney disease. cost-effectiveness potential to address health inequities countries underscore value a public strategy. Policymakers are encouraged consider viable option enhance outcomes reduce low-resource settings.

Язык: Английский

Процитировано

1

Association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in population with cardiovascular-kidney-metabolic syndrome stages 0–4: evidence from a large cohort study DOI Creative Commons

Fan-Shun Guo,

Jia‐Hao Dou, Junxiang Wang

и другие.

Diabetology & Metabolic Syndrome, Год журнала: 2025, Номер 17(1)

Опубликована: Март 28, 2025

The Cardiovascular-kidney-metabolic (CKM) syndrome is a health disorder caused by interactions between cardiovascular disease, kidney and metabolism-related risk factors. stress hyperglycemia ratio (SHR) has been shown to correlate with the prognosis of participants diabetes mellitus, heart failure, myocardial infarction. However, predictive value SHR in CKM population unclear requires further exploration. This study analyzed 19,345 from National Health Nutrition Examination Survey (1999–2018). was staged according American Heart Association (AHA) guidelines. calculated using fasting blood glucose (FBG) glycated hemoglobin type A1c (HbA1c). Participants were grouped into four quartiles based on SHR. primary secondary outcomes all-cause mortality mortality, respectively. Kaplan-Meier survival curves Cox proportional hazard regression models used evaluate association outcomes. Then, potential nonlinear relationship explored restricted cubic spline (RCS) analysis. We also performed subgroup analyses assess effects different variables. A total 2,736 deaths 699 recorded during median follow-up period 115 months. analysis revealed that quartile 2 had lowest for both (Log Rank P < 0.05). Multivariate demonstrated 2nd (HR = 0.84, 95% CI 0.73–0.97, 0.015) highest 4th 1.19, 1.03–1.37, 0.018), compared 1st group RCS curve U-shape points 0.89 0.91, strongly correlated population, high or low increasing death. index shows great predicting death this population.

Язык: Английский

Процитировано

0

Methods and Validity Indicators for Measuring Adherence to Statins in Secondary Cardiovascular Prevention: A Systematic Review DOI Creative Commons
Adriana López‐Pineda,

María Martínez-Muñóz,

Rauf Nouni-García

и другие.

Research Square (Research Square), Год журнала: 2025, Номер unknown

Опубликована: Апрель 1, 2025

Abstract Background Adherence to statin therapy is crucial for reducing the recurrence of cardiovascular events. Numerous methods exist measure medication adherence, including those based on prescription data, patient self-report, counting, and direct methods. It important determine which these are appropriate use in clinical practice. This systematic review aimed identify used adherence persistence statins patients undergoing secondary prevention evaluate validity indicators Methods included studies reporting and/or prevention. Medline, Embase, Scopus databases were searched from inception February, 2025. Rayyan was study selection extraction data processes. Validity adherence/persistence collected, it reported. Risk bias method evaluated using COSMIN (Consensus-based Standards Selection Health Measurement Instruments) tool. Results A total 77 included. Regarding measurement, most frequently refill records (n = 55) self-report 20). Electronic monitoring 2), self-perceived by physician 1), pill counting 1) less Direct methods, HPLC-MS/MS, combination with other indirect 5). For measuring persistence, predominant 9), while three studies, one a standardized questionnaire. Several have different populations medications. Only provides MAT questionnaire specifically adapted statins. Conclusions The predominantly indirect, relying supply Pill electronic monitoring, measurement via LC-MS/MS commonly used. Persistence primarily measured through records. None validated, thus their not recommended. There need new validated tools, incorporating gender perspective, this population. Systematic registration: CRD42023463981.

Язык: Английский

Процитировано

0

Association between weight-adjusted waist index and carotid atherosclerotic plaque in patients with type 2 diabetes in the Chinese population DOI Creative Commons
Qin Yu, Jingjing Ye,

Xunan Wu

и другие.

Diabetology & Metabolic Syndrome, Год журнала: 2025, Номер 17(1)

Опубликована: Апрель 15, 2025

Язык: Английский

Процитировано

0

Positive Association Between Ultrasonographic Fatty Liver Indicator and the Severity of Coronary Artery Disease DOI Creative Commons
Tingqiu Wang, Zhi Gang Wang, Peng Luo

и другие.

Diagnostics, Год журнала: 2025, Номер 15(10), С. 1208 - 1208

Опубликована: Май 10, 2025

Background: This study investigates the link between metabolic dysfunction-associated fatty liver disease (MAFLD) and coronary artery (CAD) using ultrasonographic indicator (US-FLI) to assess steatosis. Methods: A total of 204 patients were included, with hepatic steatosis evaluated through ultrasound characteristics, diagnosing when US-FLI was ≥2. CAD severity determined SYNTAX score (SS), categorizing 100 into mild (SS ≤ 22) moderate-severe (MS) ≥ 23) groups. The association SS in MAFLD multivariate logistic regression model. receiver operating characteristic curve applied determine accuracy, sensitivity, specificity predicting SS. Results: In analysis, an independent predictor group (OR = 1.194, 95% CI: 1.008–1.414, p 0.040) MS 1.262, 1.025–1.553, 0.028). a value 2 found be optimal threshold point for (AUC 0.620, 0.509–0.713, 0.039), sensitivity 65.22% 55.56%. diagnostic performance significantly improved combined type diabetes mellitus (T2DM) 0.732, 0.632–0.832, < 0.001), 77.78%. Conclusions: independently positively associated severity. T2DM had better CAD.

Язык: Английский

Процитировано

0

Methods and validity indicators for measuring adherence to statins in secondary cardiovascular prevention: a systematic review DOI Creative Commons
Adriana López‐Pineda,

María Martínez-Muñóz,

Rauf Nouni-García

и другие.

Systematic Reviews, Год журнала: 2025, Номер 14(1)

Опубликована: Май 15, 2025

Adherence to statin therapy is crucial for reducing the recurrence of cardiovascular events. Numerous methods exist measure medication adherence, including those based on prescription data, patient self-report, counting, and direct methods. It important determine which these are appropriate use in clinical practice. This systematic review aimed identify used adherence persistence statins patients undergoing secondary prevention evaluate validity indicators included studies reporting and/or prevention. Medline, Embase, Scopus databases were searched from inception February 2025. Rayyan was study selection extraction data processes. Validity adherence/persistence collected; it reported. Risk bias method evaluated using COSMIN (Consensus-based Standards Selection Health Measurement Instruments) tool. A total 77 included. Regarding measurement, most frequently refill records (n = 55) self-report 20). Electronic monitoring 2), self-perceived by physician 1), pill counting 1) less Direct methods, HPLC-MS/MS, combination with other indirect 5). For measuring persistence, predominant 9), while three studies, one a standardized questionnaire. Several have different populations medications. Only provides MAT questionnaire specifically adapted statins. The predominantly indirect, relying supply Pill electronic monitoring, measurement via LC-MS/MS commonly used. Persistence primarily measured through records. None validated; thus, their not recommended. There need new validated tools, incorporating gender perspective, this population. PROSPERO CRD42023463981.

Язык: Английский

Процитировано

0